How much cash does Fulgent Genetics, Inc. generate?

Fulgent Genetics, Inc. (FLGT) generated -$105.6M in operating cash flow over the trailing twelve months.

What is Fulgent Genetics, Inc.'s free cash flow?

After $23.1M of capital expenditures, Fulgent Genetics, Inc.'s free cash flow was -$118.2M over the trailing twelve months, down 138.2% year over year.

Where does Fulgent Genetics, Inc.'s cash flow data come from?

Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Fulgent Genetics, Inc. FLGT Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$75.01M-79.1%	-$61.63M-40.6%	-$44.17M+74.3%	-$52.04M+69.5%	-$41.87M+75.8%
Depreciation and amortization	$24.2M+0.1%	$24.12M-3.2%	$24.2M-4.2%	$24.09M-6.5%	$24.18M-6.7%
Stock-based compensation	$38.92M-10.6%	$39.58M-11.0%	$40.71M-10.5%	$41.92M-7.8%	$43.51M-1.5%
Deferred income taxes	-$2.2M+33.5%	-$1.21M+67.5%	-$1.47M+48.6%	-$2.97M-116%	-$3.31M-121%
Gain (loss) on sale of assets	——	——	——	——	-$146K—
Provision for credit losses	$6.76M—	$7.65M—	——	——	——
Change in accounts receivable	——	——	——	$27.69M—	$22.31M—
Change in accounts payable	$800K—	$550K—	——	——	——
Change in accrued liabilities	$14.27M—	$8.91M—	——	——	——
Change in other assets	——	——	——	——	-$1.03M—
Other working capital changes	——	——	-$13K—	-$31K—	——
Change in deferred revenue	——	——	——	——	$54K—
Change in income taxes payable/receivable	-$108.09M—	-$104.94M—	-$3.6M—	-$27.09M—	——
Non-cash operating lease expense	$1.77M-32.1%	$1.76M-53.1%	$1.67M-65.1%	$1.79M—	$2.6M—
Change in operating lease liabilities	-$1.65M+36.8%	-$1.63M+56.9%	-$1.66M+65.5%	-$1.79M+69.2%	-$2.61M—
Net cash from operating activities	——	——	——	-$25.09M-168%	$9.36M-77.8%
Capital expenditures	$23.06M-43.7%	$22.57M-44.0%	$21.37M-46.1%	$34.86M+39.3%	$40.98M+69.1%
Acquisitions, net of cash acquired	——	——	——	——	$0-100%
Proceeds from sale of property, plant and equipment	——	——	——	——	$57K-93.2%
Net cash from investing activities	$94.58M—	$111.37M—	$72.76M—	——	——
Repurchases of common stock	——	——	——	——	——
Repayments of debt	——	——	——	——	——
Proceeds from issuance of common stock	——	——	——	——	$38.25K+155%
Payments for finance leases	$351K-35.6%	$399K-26.7%	$447K-18.1%	$494K-8.5%	$545K-13.9%
Taxes paid for net share settlement	$5.35M+72.3%	$3.04M+4.7%	$2.83M-24.9%	$2.91M-24.7%	$3.1M-12.4%
Net cash from financing activities	-$48.45M-267%	-$14.79M-205%	-$14.58M+52.1%	-$14.7M+57.2%	-$13.21M+73.3%
Effect of exchange rate changes on cash	$97K+288%	$105K+291%	-$104K—	$38K—	$25K—
Net increase (decrease) in cash	-$43.88M—	-$4.95M—	$59.6M—	$22.9M—	——
Interest paid	——	——	——	——	$134K—
Income taxes paid	——	——	$33.88M+24.5%	$58.49M+2,214%	$26.34M+812%
Asset Impairment Charges Excluding Goodwill Impairment Loss	——	$9.93M-1.5%	$9.96M+31.9%	$10M+98.5%	$10.04M+299%
Gain/(loss) on dispositions, net	——	——	——	——	-$146K—
Accrued expenses and other liabilities	$14.27M—	$8.91M—	——	——	——
Increase Decrease In Customer Deposit	——	——	$1.6M—	$1.3M—	——
Operating lease liabilities	-$1.65M+36.8%	-$1.63M+56.9%	-$1.66M+65.5%	-$1.79M+69.2%	-$2.61M—
Increase (Decrease) in Other Operating Assets	——	——	——	——	-$1.03M—
Investment Income Net Amortization Of Discount And Premium	$4.34M-28.0%	$5.1M-8.1%	$5.71M+3.1%	$5.94M+10.3%	$6.02M+30.5%
Operating lease right-of-use asset amortization	$1.77M-32.1%	$1.76M-53.1%	$1.67M-65.1%	$1.79M—	$2.6M—
Other Noncash Income (Expense)	——	——	-$13K—	-$31K—	——
Accounts Receivable, Credit Loss Expense (Reversal)	$6.76M—	$7.65M—	——	——	——
Unrecognized Tax Benefits Operating Activities	-$998K—	-$936K—	$1.33M—	$1.46M—	——
Proceeds from disposals of property, plant and equipment	——	——	——	——	$57K-93.2%
Finance Lease, Principal Payments	$351K-35.6%	$399K-26.7%	$447K-18.1%	$494K-8.5%	$545K-13.9%
Repayments Of Notes Payable	——	——	——	——	——
Increase Decrease In Contract With Customer Liability	——	——	——	——	$54K—
Increase Decrease In Operating Lease Liability	-$1.65M+36.8%	-$1.63M+56.9%	-$1.66M+65.5%	-$1.79M+69.2%	-$2.61M—
Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1	——	——	——	——	——
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1	——	——	——	——	——
Leased assets obtained in exchange for operating lease liabilities	——	——	——	——	——
Income Taxes Paid, Net	——	——	——	——	——
Free cash flow	-$118.23M—	-$129.27M—	——	——	——
Free cash flow	-$118.23M—	-$129.27M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Fulgent Genetics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Fulgent Genetics, Inc. generate?: Fulgent Genetics, Inc. (FLGT) generated -$105.6M in operating cash flow over the trailing twelve months.
What is Fulgent Genetics, Inc.'s free cash flow?: After $23.1M of capital expenditures, Fulgent Genetics, Inc.'s free cash flow was -$118.2M over the trailing twelve months, down 138.2% year over year.
Where does Fulgent Genetics, Inc.'s cash flow data come from?: Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.